Fierce Biotech Layoff Tracker 2025: Elevation eliminates 70% of staff; bit.bio cuts 25% of workforce
All pre-clinical programs will also be paused. Story Feb. 5 - Viracta Therapeutics: The cancer biotech has closed its doors, laying off all employees and winding down operations. Story Feb. 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback